Menu

CRISPR Therapeutics AG CRSP

Full chart Compare
Set alert

Price alert · CRSP

All alert types
50.04 USD -0.03 (-0.06%)

At closeNov 9, 2026, 7:33 PM EST

50.55 +0.51 +1.02%

After hours · Nov 9, 7:33 PM ET

48.71 Day range 51.52
44.12 52-week range 63.45
YTD
-4.58%
1 year
-9.22%

Revenue & Expenses

Net Loss → Expenses: $581.60MExpenses → Gross Loss: $229.45MExpenses → Selling, General & Admin: $73.54MExpenses → Research & Development: $265.33MExpenses → Other Expenses: $9.65MExpenses → Income Tax: $3.63MRevenue → Cost of Revenue: $3.51MNet Loss$581.60MCost of Revenue$232.96MExpenses$581.60MGross Loss$229.45MSelling, General & Admin$73.54MResearch & Development$265.33MOther Expenses$9.65MIncome Tax$3.63MRevenue$3.51M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

CRSP annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
3.51M37.31M371.21M1.20M914.96M
3.51M37.31M371.21M1.20M914.96M
3.51M37.31M371.21M1.20M914.96M
668.08M503.88M593.74M674.36M541.43M
498.29M430.90M517.58M571.89M441.75M
73.54M72.98M76.16M102.46M99.69M
-664.57M-466.57M-222.54M-673.16M373.53M
3.63M3.59M2.89M-325.00K1.87M
-581.60M-366.25M-153.61M-650.17M377.66M
-581.60M-366.25M-153.61M-650.17M377.66M
-581.60M-366.25M-153.61M-650.17M377.66M
-581.60M-366.25M-153.61M-650.17M377.66M
-6.47-4.34-1.94-8.364.97
-6.47-4.34-1.94-8.364.97
-6.47-4.34-1.94-8.364.70
-577.97M-362.67M-150.72M-650.50M379.53M
-577.97M-362.67M-150.72M-650.50M379.53M
89.93M84.36M79.22M77.75M75.95M
89.93M84.36M79.22M77.75M80.39M